UK markets open in 4 hours 57 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
320.76+4.36 (+1.38%)
At close: 04:00PM EST
320.29 -0.47 (-0.15%)
After hours: 07:16PM EST
Full screen
Trade prices are not sourced from all markets
Previous close316.40
Open318.55
Bid318.00 x 800
Ask319.38 x 900
Day's range315.18 - 321.52
52-week range202.00 - 323.61
Volume1,539,420
Avg. volume1,502,019
Market cap82.336B
Beta (5Y monthly)0.43
PE ratio (TTM)25.16
EPS (TTM)12.75
Earnings date24 Jan 2023 - 30 Jan 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est324.62
  • Zacks

    Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know

    Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $320.76, moving +1.38% from the previous trading session.

  • Motley Fool

    3 Growth Stocks That Are Too Cheap to Ignore

    The stock market hates uncertainty, and the global factors driving the market in 2022 have understandably left many investors feeling frustrated. While no one can predict when this volatile period will wrap up, the history of the stock market has shown that patient investors who maintain stakes in great businesses can sustain and compound rewarding returns with time. Currently, the company relies on its portfolio of cystic fibrosis (CF) medicines to drive revenue and profits, and it continues to deliver on both fronts year after year.

  • Zacks

    Lilly's (LLY) Donanemab Betters Biogen's Alzheimer's Drug

    Data from a phase III early symptomatic Alzheimer's disease study shows that Eli Lilly's (LLY) donanemab leads to a significant reduction of amyloid buildup in the brain and P-tau in the blood after six months.